Member Info for elrico

Toyin,

I’ll try and make some sense of how they have arrived at those quite astonish numbers at this stage.

I’m recording a podcast Friday evening.

You know where I am if you have any Qs.

Mad,

There is always an element of nervousness when a share price goes into reverse. If investors think about it, they have not been forward-thinking enough. It was always clear to peeps paying attention that SBTX would need a mix of equity, CLN and debt against accretive assets acquired; SA made this clear, not once, but twice. We also knew the Company needed cash as an insurance policy against further Croda delays, so its prudent.

As for Cenkos's conspiracies, assuming there will be an equity raise, the broker is doing what needs to be done. The SP raced ahead after the interview, which I requested, not SA because I felt investors needed some TLC. SA agreed to this out of respect. However, the SP perhaps responded more than anyone anticipated, which creates a discount that may be uncomfortable, hence why the price has dropped. Given the timing of the interview and the price at the time, I am making a guess, a finger-in-the-air job, that we are over the worst. If I am right, Cenkos have done their job protecting SBTX from discount placing for friends and relations, the likely next conspiracy.

Hi Farris,

Speaking as a person of faith, I always have faith. To answer directly to your questions, yes, I have faith that progress is real and tangible this time. Imminent requires much more faith than I currently have, not least because it is out of OPTI's hands at the pace partners progress.

Have I added? I do not hold Alex and Josh, my sons, hold OPTI, as does Mike Caine. However, as I was discussing with Aquae via email yesterday, I am currently being bullied by Alex. His view is I should buy OPTI. He has a lot of conviction. I will buy back in, most likely in the New Year, at which point I will declare it. Alex will continue to take the lead on updates.

This was discussed, and further clarity to add to what TW gleaned yesterday. https://open.substack.com/pub/lemminginvestor/p/optibiotix-health-plc-ca2?r=kcv2o&utm_campaign=post&utm_medium=web

Excited! #POLB announces former #AmrytPharma execs are joining Poolbeg Pharma leadership! With their proven track record, could repeat building a $billion-dollar biopharma💡🔬 #biotech https://lemminginvestor.substack.com

https://lemminginvestor.substack.com/

Hi Farris,

I have clarification. All good. See the note under the second video link. I hope this helps.

https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-64d

Https://twitter.com/LEMMINGINVESTOR/status/1722219988537471203

Hi All,

I’ve been a tad lazy by adding the Zoom to Alex article on the commercial update.

Have a fab weekend.

https://is.gd/1enzIx

OptiBiotix expands product range on Walmart in the USA’  seehttps://www.walmart.com/search?q=Optibiotix+Health&facet=brand:Optibiotix+Health 

This adds to their gummies, which have been in Walmart for a while as part of Dietworks and are growing rapidly.https://www.walmart.com/ip/DietWorks-Weight-Loss-Supplements-Gummies-Raspberry-60-Count/296415342

Poolbeg Pharma PLC 📢 Poolbeg Pharma, focused on diseases with high unmet needs, is hosting an investors & analysts meeting on the POLB 001 Oncology Programme. Our main research emphasis? Tackling Cytokine Release Syndrome (CRS) - a major challenge in cancer immunotherapy treatments.

https://lemminginvestor.substack.com/p/poolbeg-pharma-plc-c48

I'll be removing Toyin's Porche headlamp to sell on eBay.

Winterfloods can bend the knee, I am not letting mine do.

Not until the funding flippers have taken their profits.

TD,

The monthly cash burn is reducing; by how much, we do not know, but we suspect we will have a better idea by the end of November. Croda funds the clinical trials and studies related to SkinBiotix and the lysate.

In the case of any accretive acquisition, the payment will be a combination of equity, CLN, and debt. Any equity raise will likely be minimal and won't have a significant discount. In a challenging market, the last discount was just 7%. This indicates a high level of confidence in the market for SBTX, possibly due to the considerable insurance policy that Croda offers for the very near term and years after that.

I invite you to digest the most recent interviews conducted by myself, with Stuart Ashman.

https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-64d - October

https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-35b - Septeber

I sincerely hope not; I would like an opportunity to buy first. :)

Poolbeg Pharma is on a mission to revolutionize metabolic condition treatment with an innovative oral drug. With strategic partnerships and funding in the pipeline, they're set to make a big impact and preserve their strong cash reserves of £14.1M as of June 30, 2023.

https://lemminginvestor.substack.com/p/poolbeg-pharma-plc-cad

For those of you wondering where jonas copied the content from...

https://lemminginvestor.substack.com/p/aptamer-group-plc

https://twitter.com/LEMMINGINVESTOR

Https://www.insidermedia.com/news/north-east/life-sciences-firm-on-the-acquisition-trail

The last time we hit the current resistance level, we ran up to 75p. Granted, we had established a £1.2m forecast. What will the catalyst be this time? An accretive acquisition, and someone tucked away a min of 200k right on the resistance level. Someone is confident.

It wasn't me :)

Https://twitter.com/LEMMINGINVESTOR/status/1717565917431771525

Well that went well. A good week all round.

Thanks for the support Nick. I think we are on the same page as far as reading SA’s comments.

Some light relief for counter to the bullying. 🤗

It’s difficult to know parody from insanity these days. https://www.instagram.com/reel/CxV3e7URCoO/